Stocktoria

Lyra Therapeutics, Inc. LYRA

OTC · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2020-05-01

Lyra Therapeutics, Inc. statistics & valuation

Market cap$1.2M
P / S3.1×
Net margin-7266.1%
FCF margin-7280.2%
Return on capital-116.7%

Market cap as of 2026-07-01. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-15267.70% -4055.60% -4023.10% -6090.90% -7266.10% 2019202020212022202320242025
Gross margin (%)
2019202020212022202320242025
Operating margin (%)
-15303.50% -4131.00% -4308.10% -6280.80% -7794.50% 2019202020212022202320242025
Return on equity (%)
-29.70% -126.80% -68.50% -70.10% -805.90% 2019202020212022202320242025
Shares outstanding
230860 12.9M 13.0M 31.8M 57.2M 1.3M 1.8M 2019202020212022202320242025
Net debt ($)
2019202020212022202320242025
Share buybacks ($)
2019202020212022202320242025
Return on assets (%)
-109.00% -27.40% -79.30% -50.30% -44.00% -140.80% -80.10% 2019202020212022202320242025
Free cash flow margin (%)
-10247.40% -3195.10% -4130.40% -4716.40% -7280.20% 2019202020212022202320242025
Debt / equity (×)
2019202020212022202320242025
EPS ($)
-$3.35 -$1.83 -$1.26 -$71.75 -$18.62 2019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Operating margin-7794.5%-6280.8%-4308.1%-4131.0%-15303.5%——
Net margin-7266.1%-6090.9%-4023.1%-4055.6%-15267.7%——
FCF margin-7280.2%-4716.4%-4130.4%-3195.1%-10247.4%——
Return on assets-80.1%-140.8%-44.0%-50.3%-79.3%-27.4%-109.0%
Return on equity269.8%-805.9%-70.1%-68.5%-126.8%-29.7%13.2%
Current ratio1.713.415.356.972.6315.541.94

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.